Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Search research articles

Related Experiment Videos

Immunostimulating reconstituted influenza virosomes.

Rinaldo Zurbriggen¹

¹Pevion Biotech Ltd, Rehhagstrasse 79, Bern 3018, Switzerland. rinaldo.zurbriggen@pevion.com

|January 28, 2003

Summary

Immunostimulating reconstituted influenza virosomes (IRIVs) are a versatile liposomal carrier system. These virosomes effectively deliver various molecules to immune cells, enhancing targeted immune responses.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Development of influenza virosome-based synthetic malaria vaccines.

Expert opinion on drug discovery·2013

Same author

A virosomal vaccine against candidal vaginitis: immunogenicity, efficacy and safety profile in animal models.

Vaccine·2012

Same author

Immunogenicity of a virosomally-formulated Plasmodium falciparum GLURP-MSP3 chimeric protein-based malaria vaccine candidate in comparison to adjuvanted formulations.

Malaria journal·2011

Same author

Virosome-formulated Plasmodium falciparum AMA-1 & CSP derived peptides as malaria vaccine: randomized phase 1b trial in semi-immune adults & children.

PloS one·2011

Same author

Influenza virosomes as a vaccine adjuvant and carrier system.

Expert review of vaccines·2011

Same author

Immunization with HIV-1 gp41 subunit virosomes induces mucosal antibodies protecting nonhuman primates against vaginal SHIV challenges.

Immunity·2011

Area of Science:

Biotechnology and Pharmaceutical Sciences
Immunology
Drug Delivery Systems

Background:

Immunostimulating reconstituted influenza virosomes (IRIVs) represent an advanced liposomal carrier technology.
Influenza hemagglutinin and neuraminidase proteins are integral to the IRIV lipid bilayer, conferring fusogenic properties.

Purpose of the Study:

To highlight the capabilities of IRIVs as a drug delivery system.
To emphasize the targeted delivery of antigens for specific immune responses.
To showcase the versatility of IRIVs in delivering diverse biomolecules.

Main Methods:

Utilizing IRIVs, a liposomal carrier system.
Incorporating influenza hemagglutinin and neuraminidase into the lipid bilayer.
Leveraging the fusogenic activity of IRIVs for cellular entry.

Main Results:

IRIVs demonstrate successful intercalation of viral proteins into their lipid bilayer.
The system is approved for human use, indicating safety and efficacy.
IRIVs facilitate targeted delivery of antigens to elicit specific cellular or humoral immune responses.
The carrier system effectively delivers proteins, RNA/DNA, peptides, and mimetics to immunocompetent cells.

Conclusions:

IRIVs are a proven and effective liposomal platform for targeted antigen delivery.
The technology enables precise modulation of immune responses, targeting either cellular or humoral immunity.
IRIVs offer a versatile solution for delivering a wide range of therapeutic molecules to immune cells.

Related Experiment Videos